Abstract
BackgroundAdolescent obesity is an important health issue. Non-surgical weight management programs, even the most aggressive, have shown modest weight reduction results. Laparoscopic sleeve gastrectomy (LSG) is gaining reliability as a low surgical risk bariatric procedure with proper efficiency for this age group. The aim of this study was to present our initial experience with LSG in morbidly obese adolescents and to report short-term clinical and metabolic outcome.ResultsMean age was 16.43 years, and mean preoperative weight and body mass index (BMI) were 132.68 kg and 48.90 respectively. Mean excess weight loss (EWL) was 54.11 kg 1 year after LSG, corresponding to 74 EWL% as well as mean BMI loss (BML) of 19.89. LSG improved fatty infiltration of the liver in 75% of cases and other comorbidities in 100% of patients.ConclusionsLSG proved to be a safe procedure with significant short-term clinical and metabolic success for adolescent obesity.
Highlights
Adolescent obesity is an important health issue
Adolescent obesity is a progressive disease causing significant morbidity [1,2,3]. It is associated with serious co-morbidities, such as hypertension, diabetes mellitus, non-alcoholic fatty liver disease (NAFLD), and dyslipidemia [4, 5]
The aim of this study was to present our initial experience with Laparoscopic sleeve gastrectomy (LSG) in morbidly obese adolescents and to report feasibility and short-term clinical results as a primary outcome and
Summary
Non-surgical weight management programs, even the most aggressive, have shown modest weight reduction results. The aim of this study was to present our initial experience with LSG in morbidly obese adolescents and to report short-term clinical and metabolic outcome. Adolescent obesity is a progressive disease causing significant morbidity [1,2,3]. It is associated with serious co-morbidities, such as hypertension, diabetes mellitus, non-alcoholic fatty liver disease (NAFLD), and dyslipidemia [4, 5]. The aim of this study was to present our initial experience with LSG in morbidly obese adolescents and to report feasibility and short-term clinical results as a primary outcome and
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
